Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05445427 · ClinicalTrials.gov registry record · NA
Vagal Nerve Stimulation for Post COVID Fatigue
A NA study of Fatigue and Headache, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT05445427: Completed NA study of Fatigue and Headache, sponsored by Mayo Clinic.
NCT05445427 is a NA study of Fatigue and Headache that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05445427, a NA study of Fatigue and Headache, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.
Primary Outcome
Measurement is the change in scoring determined through patients' self-reported Post-COVID Functional Status Score survey, which assesses COVID-19 symptom impact on a grading scale of 0 = no limitations to 4 = severe limitations. Thus, higher scores are a worse outcome, and a change indicating an increase is a worsening of functional status.
Conditions Studied
Interventions
- DEVICE vagal nerve stimulator
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-12-21 |
| Est. Completion | 2024-03-28 |
| Phase | NA |
What the finished NCT05445427 record still lists
NCT05445427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which vagal nerve stimulator is the first listed.
NCT05445427 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05445427 about?
NCT05445427 is a clinical study titled "Vagal Nerve Stimulation for Post COVID Fatigue". The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.
What is the current status of trial NCT05445427?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-12-21. Estimated completion is 2024-03-28.
What conditions does trial NCT05445427 study?
This clinical trial studies the following conditions: Fatigue, Headache, Post COVID Syndrome.
What interventions are being tested in trial NCT05445427?
The interventions under investigation include: vagal nerve stimulator (DEVICE).
Who is sponsoring clinical trial NCT05445427?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05445427 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05445427's enrollment target sits among peer trials
18 97th of 109 higher than 12 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI